Effect of cigarette smoke exposure and structural modifications on the α-1 Antitrypsin interaction with caspases.

Angelia Lockett, Mary Van Demark, Yuan Gu, Kelly S. Schweitzer, Ninotchka Sigua, Krzysztof Kamocki, Iwona Fijalkowska, Jana Garrison, Amanda J. Fisher, Karina Serban, Robert A. Wise, Terence R. Flotte, Christian Mueller, Robert Presson, Horia I. Petrache, Rubin M. Tuder, Irina Petrache

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

α-1 Antitrypsin (A1AT) is a serpin with a major protective effect against cigarette smoke-induced emphysema development, and patients with mutations of the A1AT gene display a markedly increased risk for developing emphysema. We reported that A1AT protects lung endothelial cells from apoptosis and inhibits caspase-3 activity. It is not clear if cigarette smoking or A1AT mutations alter the caspase-3 inhibitory activity of A1AT and if this serpin alters the function of other caspases. We tested the hypothesis that the caspase-3 inhibitory activity of A1AT is impaired by cigarette smoking and that the A1AT RCL, the key antiprotease domain of the serpin, is required for its interaction with the caspase. We examined the caspase-3 inhibitory activity of human A1AT purified from plasma of actively smoking and nonsmoking individuals, either affected or unaffected with chronic obstructive pulmonary disease. We also tested the caspase inhibitory activity of two mutant forms of A1AT, the recombinant human piZZ and the RCL-deleted (RCL-null) A1AT forms. A1AT purified from the blood of active smokers exhibited marked attenuation in its caspase-3 inhibitory activity, independent of disease status. In vitro exposure of the normal (MM) form of A1AT to cigarette smoke extract reduced its ability to interact with caspase-3, measured by isothermal titration calorimetry, as did the deletion of the RCL, but not the ZZ point mutation. In cell-free assays A1AT was capable of inhibiting all executioner caspases, -3, -7 and especially -6, but not the initiator or inflammatory caspases. The inhibitory effect of A1AT against caspase-6 was tested in vivo, where overexpression of both human MM and ZZ-A1AT via adeno-associated virus transduction significantly protected against apoptosis and against airspace damage induced by intratracheal instillation of caspase-6 in mice. These data indicate a specific inhibitory effect of A1AT on executioner caspases, which is profoundly attenuated by active exposure to cigarette smoking and is dependent on the protein RCL, but is not affected by the PiZZ mutation.

Original languageEnglish (US)
Pages (from-to)445-454
Number of pages10
JournalMolecular Medicine
Volume18
Issue number1
StatePublished - 2012

Fingerprint

Caspases
Smoke
Tobacco Products
Caspase 3
Serpins
Smoking
Caspase 6
Emphysema
Mutation
Apoptosis
Caspase 7
Dependovirus
Calorimetry
Aptitude
Protease Inhibitors
Point Mutation
Human Activities
Chronic Obstructive Pulmonary Disease
Endothelial Cells
Lung

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Effect of cigarette smoke exposure and structural modifications on the α-1 Antitrypsin interaction with caspases. / Lockett, Angelia; Van Demark, Mary; Gu, Yuan; Schweitzer, Kelly S.; Sigua, Ninotchka; Kamocki, Krzysztof; Fijalkowska, Iwona; Garrison, Jana; Fisher, Amanda J.; Serban, Karina; Wise, Robert A.; Flotte, Terence R.; Mueller, Christian; Presson, Robert; Petrache, Horia I.; Tuder, Rubin M.; Petrache, Irina.

In: Molecular Medicine, Vol. 18, No. 1, 2012, p. 445-454.

Research output: Contribution to journalArticle

Lockett, A, Van Demark, M, Gu, Y, Schweitzer, KS, Sigua, N, Kamocki, K, Fijalkowska, I, Garrison, J, Fisher, AJ, Serban, K, Wise, RA, Flotte, TR, Mueller, C, Presson, R, Petrache, HI, Tuder, RM & Petrache, I 2012, 'Effect of cigarette smoke exposure and structural modifications on the α-1 Antitrypsin interaction with caspases.', Molecular Medicine, vol. 18, no. 1, pp. 445-454.
Lockett, Angelia ; Van Demark, Mary ; Gu, Yuan ; Schweitzer, Kelly S. ; Sigua, Ninotchka ; Kamocki, Krzysztof ; Fijalkowska, Iwona ; Garrison, Jana ; Fisher, Amanda J. ; Serban, Karina ; Wise, Robert A. ; Flotte, Terence R. ; Mueller, Christian ; Presson, Robert ; Petrache, Horia I. ; Tuder, Rubin M. ; Petrache, Irina. / Effect of cigarette smoke exposure and structural modifications on the α-1 Antitrypsin interaction with caspases. In: Molecular Medicine. 2012 ; Vol. 18, No. 1. pp. 445-454.
@article{2a43dbfe23af43c095990e440f7186b1,
title = "Effect of cigarette smoke exposure and structural modifications on the α-1 Antitrypsin interaction with caspases.",
abstract = "α-1 Antitrypsin (A1AT) is a serpin with a major protective effect against cigarette smoke-induced emphysema development, and patients with mutations of the A1AT gene display a markedly increased risk for developing emphysema. We reported that A1AT protects lung endothelial cells from apoptosis and inhibits caspase-3 activity. It is not clear if cigarette smoking or A1AT mutations alter the caspase-3 inhibitory activity of A1AT and if this serpin alters the function of other caspases. We tested the hypothesis that the caspase-3 inhibitory activity of A1AT is impaired by cigarette smoking and that the A1AT RCL, the key antiprotease domain of the serpin, is required for its interaction with the caspase. We examined the caspase-3 inhibitory activity of human A1AT purified from plasma of actively smoking and nonsmoking individuals, either affected or unaffected with chronic obstructive pulmonary disease. We also tested the caspase inhibitory activity of two mutant forms of A1AT, the recombinant human piZZ and the RCL-deleted (RCL-null) A1AT forms. A1AT purified from the blood of active smokers exhibited marked attenuation in its caspase-3 inhibitory activity, independent of disease status. In vitro exposure of the normal (MM) form of A1AT to cigarette smoke extract reduced its ability to interact with caspase-3, measured by isothermal titration calorimetry, as did the deletion of the RCL, but not the ZZ point mutation. In cell-free assays A1AT was capable of inhibiting all executioner caspases, -3, -7 and especially -6, but not the initiator or inflammatory caspases. The inhibitory effect of A1AT against caspase-6 was tested in vivo, where overexpression of both human MM and ZZ-A1AT via adeno-associated virus transduction significantly protected against apoptosis and against airspace damage induced by intratracheal instillation of caspase-6 in mice. These data indicate a specific inhibitory effect of A1AT on executioner caspases, which is profoundly attenuated by active exposure to cigarette smoking and is dependent on the protein RCL, but is not affected by the PiZZ mutation.",
author = "Angelia Lockett and {Van Demark}, Mary and Yuan Gu and Schweitzer, {Kelly S.} and Ninotchka Sigua and Krzysztof Kamocki and Iwona Fijalkowska and Jana Garrison and Fisher, {Amanda J.} and Karina Serban and Wise, {Robert A.} and Flotte, {Terence R.} and Christian Mueller and Robert Presson and Petrache, {Horia I.} and Tuder, {Rubin M.} and Irina Petrache",
year = "2012",
language = "English (US)",
volume = "18",
pages = "445--454",
journal = "Molecular Medicine",
issn = "1076-1551",
publisher = "Feinstein Institute for Medical Research",
number = "1",

}

TY - JOUR

T1 - Effect of cigarette smoke exposure and structural modifications on the α-1 Antitrypsin interaction with caspases.

AU - Lockett, Angelia

AU - Van Demark, Mary

AU - Gu, Yuan

AU - Schweitzer, Kelly S.

AU - Sigua, Ninotchka

AU - Kamocki, Krzysztof

AU - Fijalkowska, Iwona

AU - Garrison, Jana

AU - Fisher, Amanda J.

AU - Serban, Karina

AU - Wise, Robert A.

AU - Flotte, Terence R.

AU - Mueller, Christian

AU - Presson, Robert

AU - Petrache, Horia I.

AU - Tuder, Rubin M.

AU - Petrache, Irina

PY - 2012

Y1 - 2012

N2 - α-1 Antitrypsin (A1AT) is a serpin with a major protective effect against cigarette smoke-induced emphysema development, and patients with mutations of the A1AT gene display a markedly increased risk for developing emphysema. We reported that A1AT protects lung endothelial cells from apoptosis and inhibits caspase-3 activity. It is not clear if cigarette smoking or A1AT mutations alter the caspase-3 inhibitory activity of A1AT and if this serpin alters the function of other caspases. We tested the hypothesis that the caspase-3 inhibitory activity of A1AT is impaired by cigarette smoking and that the A1AT RCL, the key antiprotease domain of the serpin, is required for its interaction with the caspase. We examined the caspase-3 inhibitory activity of human A1AT purified from plasma of actively smoking and nonsmoking individuals, either affected or unaffected with chronic obstructive pulmonary disease. We also tested the caspase inhibitory activity of two mutant forms of A1AT, the recombinant human piZZ and the RCL-deleted (RCL-null) A1AT forms. A1AT purified from the blood of active smokers exhibited marked attenuation in its caspase-3 inhibitory activity, independent of disease status. In vitro exposure of the normal (MM) form of A1AT to cigarette smoke extract reduced its ability to interact with caspase-3, measured by isothermal titration calorimetry, as did the deletion of the RCL, but not the ZZ point mutation. In cell-free assays A1AT was capable of inhibiting all executioner caspases, -3, -7 and especially -6, but not the initiator or inflammatory caspases. The inhibitory effect of A1AT against caspase-6 was tested in vivo, where overexpression of both human MM and ZZ-A1AT via adeno-associated virus transduction significantly protected against apoptosis and against airspace damage induced by intratracheal instillation of caspase-6 in mice. These data indicate a specific inhibitory effect of A1AT on executioner caspases, which is profoundly attenuated by active exposure to cigarette smoking and is dependent on the protein RCL, but is not affected by the PiZZ mutation.

AB - α-1 Antitrypsin (A1AT) is a serpin with a major protective effect against cigarette smoke-induced emphysema development, and patients with mutations of the A1AT gene display a markedly increased risk for developing emphysema. We reported that A1AT protects lung endothelial cells from apoptosis and inhibits caspase-3 activity. It is not clear if cigarette smoking or A1AT mutations alter the caspase-3 inhibitory activity of A1AT and if this serpin alters the function of other caspases. We tested the hypothesis that the caspase-3 inhibitory activity of A1AT is impaired by cigarette smoking and that the A1AT RCL, the key antiprotease domain of the serpin, is required for its interaction with the caspase. We examined the caspase-3 inhibitory activity of human A1AT purified from plasma of actively smoking and nonsmoking individuals, either affected or unaffected with chronic obstructive pulmonary disease. We also tested the caspase inhibitory activity of two mutant forms of A1AT, the recombinant human piZZ and the RCL-deleted (RCL-null) A1AT forms. A1AT purified from the blood of active smokers exhibited marked attenuation in its caspase-3 inhibitory activity, independent of disease status. In vitro exposure of the normal (MM) form of A1AT to cigarette smoke extract reduced its ability to interact with caspase-3, measured by isothermal titration calorimetry, as did the deletion of the RCL, but not the ZZ point mutation. In cell-free assays A1AT was capable of inhibiting all executioner caspases, -3, -7 and especially -6, but not the initiator or inflammatory caspases. The inhibitory effect of A1AT against caspase-6 was tested in vivo, where overexpression of both human MM and ZZ-A1AT via adeno-associated virus transduction significantly protected against apoptosis and against airspace damage induced by intratracheal instillation of caspase-6 in mice. These data indicate a specific inhibitory effect of A1AT on executioner caspases, which is profoundly attenuated by active exposure to cigarette smoking and is dependent on the protein RCL, but is not affected by the PiZZ mutation.

UR - http://www.scopus.com/inward/record.url?scp=84865616157&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865616157&partnerID=8YFLogxK

M3 - Article

C2 - 22245800

AN - SCOPUS:84865616157

VL - 18

SP - 445

EP - 454

JO - Molecular Medicine

JF - Molecular Medicine

SN - 1076-1551

IS - 1

ER -